Literature DB >> 7111120

Fulminant hepatic failure in non-Hodgkin's lymphoma.

S Braude, A E Gimson, B Portmann, R Williams.   

Abstract

Entities:  

Mesh：

Year:  1982        PMID： 7111120      PMCID： PMC2426413          DOI： 10.1136/pgmj.58.679.301

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  9 in total

1.  Three atypical cases of Hodgkin's Disease, presenting with liver failure.

Authors:  W H FAIRBANK
Journal:  Can Med Assoc J       Date:  1953-09       Impact factor: 8.262

Review 2.  Pathology of malignant lymphomas in the liver: application in staging.

Authors:  H Kim; R F Dorfman; S A Rosenberg
Journal:  Prog Liver Dis       Date:  1976

3.  Morphological studies of 84 untreated patients subjected to laparotomy for the staging of non-Hodgkin's lymphomas.

Authors:  H Kim; R F Dorfman
Journal:  Cancer       Date:  1974-03       Impact factor: 6.860

4.  Diagnosis of liver involvement by lymphoma: results in 96 consecutive peritoneoscopies.

Authors:  C M Bagley; L B Thomas; R E Johnson; P B Chretien; V T DeVita
Journal:  Cancer       Date:  1973-04       Impact factor: 6.860

Review 5.  The management of fulminant hepatic failure.

Authors:  C Trey; C S Davidson
Journal:  Prog Liver Dis       Date:  1970

6.  Surgical experience with staging laparotomy in 125 patients with lymphoma.

Authors:  D J Ferguson; L W Allen; M L Griem; M E Moran; H Rappaport; J E Ultmann
Journal:  Arch Intern Med       Date:  1973-03

7.  Mlaignant histiocytosis. Results of combination vincristine-prednisone therapy.

Authors:  H S Kingdon; J M Baron; G E Byrne; H Rappaport
Journal:  Ann Intern Med       Date:  1970-05       Impact factor: 25.391

8.  Hodgkin's disease and the liver.

Authors:  R Cowan; J R Trounce
Journal:  Guys Hosp Rep       Date:  1973

9.  Liver disease as presenting manifestation of Hodgkin's disease.

Authors:  P N Trewby; B Portmann; D M Brinkley; R Williams
Journal:  Q J Med       Date:  1979-01
  9 in total
  8 in total

1.  Primary hepatocellular carcinoma presenting as fulminant hepatic failure in a young woman.

Authors:  L J Levy; L M Swinburne; R P Boulton; M S Losowsky
Journal:  Postgrad Med J       Date:  1986-12       Impact factor: 2.401

2.  Acute liver failure as an initial manifestation of an infiltrative hematolymphoid malignancy.

Authors:  Yasser M Bhat; Alyssa Krasinskas; Fiona E Craig; Thomas A Shaw-Stiffel
Journal:  Dig Dis Sci       Date:  2006-01       Impact factor: 3.199

3.  Acute liver failure secondary to hepatic infiltration: a single centre experience of 18 cases.

Authors:  D Rowbotham; J Wendon; R Williams
Journal:  Gut       Date:  1998-04       Impact factor: 23.059

Review 4.  Acute liver failure due to hepatic involvement by hematologic malignancy.

Authors:  T M Shehab; M S Kaminski; A S Lok
Journal:  Dig Dis Sci       Date:  1997-07       Impact factor: 3.199

Review 5.  Acute liver failure due to lymphoma. A diagnostic concern when considering liver transplantation.

Authors:  G M Woolf; L M Petrovic; S E Rojter; F G Villamil; L Makowka; L G Podesta; L S Sher; L Memsic; J M Vierling
Journal:  Dig Dis Sci       Date:  1994-06       Impact factor: 3.199

6.  Unique morphologic and clinical features of liver predominant/primary small cell carcinoma--autopsy and biopsy case series.

Authors:  Amy A Lo; Edward C Lo; Haonan Li; Wanying Zhang; Jie Liao; M Sambasivia Rao; Frank Miller; Guang-Yu Yang
Journal:  Ann Diagn Pathol       Date:  2014-02-25       Impact factor: 2.090

7.  Acute hepatic failure and multi-system organ failure secondary to replacement of the liver with metastatic melanoma.

Authors:  Gilaad G Kaplan; Shaun Medlicott; Bruce Culleton; Kevin B Laupland
Journal:  BMC Cancer       Date:  2005-06-30       Impact factor: 4.430

8.  Fulminant hepatic failure due to metastatic choroidal melanoma.

Authors:  Emmanuel Escobar-Valdivia; Roberto Monreal-Robles; Guillermo Delgado-García; Badir Hernández-Velazquez
Journal:  Caspian J Intern Med       Date:  2017
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.